Lyra Therapeutics's total assets for Q1 2025 were $56.32M, a decrease of -15.12% from the previous quarter. LYRA total liabilities were $52.44M for the fiscal quarter, a -4.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.